坪田ラボの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/09/07 | 1,101 | 1,102 | 1,065 | 1,095 | -16 | -1.4% | 285,300 |
| 2022/09/06 | 1,132 | 1,151 | 1,111 | 1,111 | -36 | -3.1% | 191,900 |
| 2022/09/05 | 1,072 | 1,153 | 1,071 | 1,147 | +50 | +4.6% | 316,900 |
| 2022/09/02 | 1,091 | 1,104 | 1,060 | 1,097 | +3 | +0.3% | 302,600 |
| 2022/09/01 | 1,160 | 1,162 | 1,083 | 1,094 | -80 | -6.8% | 524,300 |
| 2022/08/31 | 1,161 | 1,177 | 1,156 | 1,174 | -5 | -0.4% | 183,400 |
| 2022/08/30 | 1,185 | 1,199 | 1,142 | 1,179 | -3 | -0.3% | 470,400 |
| 2022/08/29 | 1,140 | 1,185 | 1,139 | 1,182 | -16 | -1.3% | 501,100 |
| 2022/08/26 | 1,207 | 1,215 | 1,158 | 1,198 | -9 | -0.7% | 538,000 |
| 2022/08/25 | 1,260 | 1,274 | 1,204 | 1,207 | -27 | -2.2% | 895,100 |
| 2022/08/24 | 1,178 | 1,241 | 1,167 | 1,234 | +83 | +7.2% | 1,295,100 |
| 2022/08/23 | 1,186 | 1,190 | 1,136 | 1,151 | -48 | -4% | 321,000 |
| 2022/08/22 | 1,182 | 1,213 | 1,153 | 1,199 | +17 | +1.4% | 551,300 |
| 2022/08/19 | 1,194 | 1,256 | 1,154 | 1,182 | +15 | +1.3% | 1,383,800 |
| 2022/08/18 | 1,092 | 1,182 | 1,091 | 1,167 | +49 | +4.4% | 1,270,700 |
| 2022/08/17 | 1,058 | 1,123 | 1,050 | 1,118 | +54 | +5.1% | 1,264,500 |
| 2022/08/16 | 1,038 | 1,076 | 1,024 | 1,064 | +12 | +1.1% | 934,800 |
| 2022/08/15 | 975 | 1,076 | 963 | 1,052 | +47 | +4.7% | 1,907,400 |
| 2022/08/12 | 1,003 | 1,039 | 1,003 | 1,005 | -10 | -1% | 535,500 |
| 2022/08/10 | 1,051 | 1,057 | 1,005 | 1,015 | -62 | -5.8% | 729,400 |
| 2022/08/09 | 1,048 | 1,102 | 1,010 | 1,077 | +9 | +0.8% | 997,800 |
| 2022/08/08 | 1,094 | 1,110 | 1,061 | 1,068 | -48 | -4.3% | 585,500 |
| 2022/08/05 | 1,125 | 1,136 | 1,102 | 1,116 | -25 | -2.2% | 393,600 |
| 2022/08/04 | 1,110 | 1,148 | 1,088 | 1,141 | +18 | +1.6% | 780,800 |
| 2022/08/03 | 1,059 | 1,150 | 1,036 | 1,123 | +42 | +3.9% | 1,063,900 |
| 2022/08/02 | 1,149 | 1,152 | 1,071 | 1,081 | -69 | -6% | 887,400 |
| 2022/08/01 | 1,128 | 1,183 | 1,092 | 1,150 | -5 | -0.4% | 1,190,300 |
| 2022/07/29 | 1,212 | 1,235 | 1,146 | 1,155 | -67 | -5.5% | 1,629,500 |
| 2022/07/28 | 1,291 | 1,306 | 1,202 | 1,222 | -9 | -0.7% | 4,254,500 |
| 2022/07/27 | 1,291 | 1,350 | 1,214 | 1,231 | -30 | -2.4% | 8,482,500 |
| 2022/07/26 | 1,111 | 1,335 | 1,056 | 1,261 | +127 | +11.2% | 10,628,500 |
| 2022/07/25 | 1,200 | 1,207 | 1,121 | 1,134 | -76 | -6.3% | 3,540,800 |
| 2022/07/22 | 1,115 | 1,240 | 1,111 | 1,210 | +110 | +10% | 7,557,900 |
| 2022/07/21 | 1,084 | 1,136 | 1,072 | 1,100 | +3 | +0.3% | 1,651,400 |
| 2022/07/20 | 1,075 | 1,139 | 1,050 | 1,097 | +32 | +3% | 2,640,500 |
| 2022/07/19 | 1,012 | 1,090 | 975 | 1,065 | +26 | +2.5% | 2,937,300 |
| 2022/07/15 | 1,157 | 1,205 | 1,003 | 1,039 | -96 | -8.5% | 5,316,300 |
| 2022/07/14 | 1,100 | 1,188 | 1,063 | 1,135 | +5 | +0.4% | 8,091,800 |
| 2022/07/13 | 1,020 | 1,244 | 1,013 | 1,130 | +104 | +10.1% | 17,273,700 |
| 2022/07/12 | 1,035 | 1,073 | 971 | 1,026 | +64 | +6.7% | 12,412,500 |
| 2022/07/11 | 849 | 962 | 835 | 962 | +150 | +18.5% | 6,231,800 |
| 2022/07/08 | 820 | 854 | 791 | 812 | +34 | +4.4% | 4,713,800 |
| 2022/07/07 | 774 | 808 | 746 | 778 | +11 | +1.4% | 4,213,400 |
| 2022/07/06 | 800 | 887 | 755 | 767 | +25 | +3.4% | 16,334,800 |
| 2022/07/05 | 732 | 775 | 700 | 742 | +15 | +2.1% | 1,945,300 |
| 2022/07/04 | 777 | 800 | 700 | 727 | -43 | -5.6% | 2,509,400 |
| 2022/07/01 | 853 | 884 | 731 | 770 | -89 | -10.4% | 5,500,600 |
| 2022/06/30 | 978 | 998 | 830 | 859 | -29 | -3.3% | 16,152,600 |
| 2022/06/29 | 723 | 888 | 722 | 888 | +150 | +20.3% | 10,615,300 |
| 2022/06/28 | 711 | 780 | 697 | 738 | +16 | +2.2% | 4,748,600 |
551～
600
件表示中 / 603件
類似銘柄と比較する
現在ご覧いただいている「坪田ラボ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 坪田ラボ | 42,400円 | +78.3% | - | 0.00% | 108.44倍 | 7.68倍 |
|
近視進行抑制、脳活性化などに強いバイオベンチャー。企業との早期契約による収益化で実績 |
| カイオム | 19,800円 | +2.6% | - | 0.00% | - | 11.67倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
| ペルセウス | 74,400円 | 0.0% | - | 0.00% | - | 6.23倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体（ＡＤＣ）開発 |
| シンバイオ | 23,000円 | -53.1% | - | 0.00% | - | 1.71倍 |
|
他社から新薬候補導入し開発、製品化。抗ウイルス薬「ブリンシドフォビル（ＢＣＶ）」開発注力 |
| ソレイジア | 4,500円 | +102.6% | - | 0.00% | - | 4.99倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
市場注目の銘柄
チャート関連のコラム
